BackBiotech Acquisition Overview

Biotech Acquisition Common Stock

Track Biotech Acquisition's common stock ($230M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$231.29M
↑ 0.56% YoYΔ $1.28M vs prior year quarter

Peer trimmed avg / median

Loading

Biotech Acquisition Common Stock History

Loading

Biotech Acquisition vs. peers: Common Stock Comparison

Loading

Biotech Acquisition Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

Biotech Acquisition (BIOT) FAQ

As of the most recent data (September 2022), BIOT shows a common stock of $230M. That compares with $230M in the prior-year period — up 0.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BIOT's common stock is now $230M (was $230M) — a 0.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Biotech Acquisition is outperforming or lagging.

Tracking BIOT's common stock over time shows whether Biotech Acquisition is scaling, shrinking, or reshaping that part of the business. The current reading is $230M That compares with $230M in the prior-year period — up 0.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has Biotech Acquisition's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $230M) with ownership activity and broader fundamentals.